MedTrace Logo

Replacing Protein Via Enteral Nutrition in a Stepwise Approach in Critically Ill Patients

NCT03480555 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-01-05

No results posted yet for this study

Summary

In this study, we will explore the feasibility of a randomized controlled trial that will compare high protein dose from ICU day 6 to 14 with moderate protein intake.

Conditions

  • Critical Illness
  • ARDS
  • Septic Shock
  • Multiple Trauma
  • Seizure Disorder
  • Hemorrhagic Shock

Interventions

DIETARY_SUPPLEMENT

Replenish Protein

Subjects randomized to this group will receive 2 g of protein/kg/day (acceptable range as 1.8 - 2.2 g of protein/kg/day) for day 6-14.

DIETARY_SUPPLEMENT

Standard protein

Subjects randomized to this group will receive 0.8 - 1 g of protein/kg/day for day 6-14

Sponsors & Collaborators

  • King Abdullah International Medical Research Center

    lead OTHER

Principal Investigators

  • Yaseen M Arabi, MD · King Abdulaziz Medical City-Ministry of National Guard

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-16
Primary Completion
2019-05-10
Completion
2019-09-10

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03480555 on ClinicalTrials.gov